ALFA Finder| Value | ₹639.1 Cr |
|---|
BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.
Fredun Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,473.70
- Market cap
- ₹2,112 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 39.9×Sector 43.0×
- Promoter holding
- 43.62%-0.95% QoQ
- FII holding
- 0.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fredun Pharmaceuticals Ltd
All →Fredun Pharmaceuticals Q2 FY27 Results: Net Profit ₹18.6 Cr, Up 97.9% YoY
Fredun Pharmaceuticals Ltd reported revenue from operations of ₹265.9 Cr (+85.2% YoY) and net profit of ₹18.6 Cr (+97.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹18.6 Cr · +97.9% YoY
Fredun Pharmaceuticals Board Meeting Date
Fredun Pharmaceuticals will hold a board meeting on 05 November 2026 to consider half-year results. Trading window stays closed until 48 hours after results.
Fredun Pharmaceuticals Convertible Warrants
Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.
Fredun Pharmaceuticals Business Update
Fredun Pharma announces strategic pet-care acquisitions, capacity expansion, and a 100% branded portfolio target by 2029. H1 FY27 business update outlines multi-pillar growth transformation.
- manufacturing infrastructure (Palghar plant)
- 90000 sq. ft.
Other results update announcements
All →Desco Infratech Results Update
Desco Infratech reported H1 FY27 revenue up 78.52% to Rs. 7,504.94 lacs and PAT up 53.97% to Rs. 950.23 lacs in a press release. Management flagged working capital pressure and a Rs. 195 crore FY27 revenue ambition.
Tata Steel Results Update
Tata Steel's consolidated EBITDA rose to Rs 10,665 crore in the September quarter, up 17% YoY. Half-year EBITDA reached Rs 20,035 crore.
Remsons Industries Results Update
Remsons Industries reported Q2 FY27 revenue growth of 17% year-on-year alongside new orders. The press release also highlights leadership changes and a joint venture exit.
Speb Adhesives Results Update
SPEB Adhesives reported H1 FY27 revenue up 35.35% to ₹3351 Lakhs, with water-based sales up 289.78%. Higher raw material costs weighed on near-term profitability.
Goldiam International Results Update
Goldiam International reported Q2 FY27 consolidated revenue up 44% to ₹2,917 million and PAT up 58%. It also declared a ₹2 interim dividend per share.
HIM Teknoforge Results Update
Him Teknoforge reported Q2 FY27 PAT of ₹5.38 Crore, up 84.8% YoY, with revenue up 27.6%. The press release also notes a recent MoU with Richard Neumayer GmbH, Germany.